Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patriarca

Showing results (781-790 of 1,012) with videos related to

Pageof 102
Sort By:
The Lancet. Haematology|July 5, 2024
Diagnosis and management of Evans syndrome in adults: first consensus recommendationsBruno Fattizzo, Monia Marchetti, Marc Michel, et al.
European Heart Journal|April 23, 2009
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stentsGiampaolo Niccoli, Domenico Schiavino, Flavia Belloni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2019
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective StudyFederica Sora, Carmen Di Grazia, Patrizia Chiusolo, et al.
Transplantation and Cellular Therapy|February 8, 2022
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance TreatmentMarta Reinoso-Segura, Teresa Caballero-Velázquez, Pilar Herrera, et al.
Obstetrics and Gynecology|February 20, 2010
Genetic analysis of the cause of endometrial osseous metaplasiaRaphael Câmara Medeiros Parente, Marisa Teresinha Patriarca, Rodrigo Soares de Moura Neto, et al.
The Oncologist|May 25, 2026
Add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: a randomized phase 3 studyJean-Jacques Kiladjian, Uma Borate, Elisabetta Abruzzese, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2017
Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple MyelomaLuisa Giaccone, Andrea Evangelista, Francesca Patriarca, et al.
Revista Brasileira De Parasitologia Veterinaria = Brazilian Journal of Veterinary Parasitology : Orgao Oficial Do Colegio Brasileiro De Parasitologia Veterinaria|July 27, 2012
Hematological alterations during experimental canine infection by Trypanosoma cruziPaulo Marcos Matta Guedes, Vanja Maria Veloso, Tiago Wilson Patriarca Mineo, et al.
Tissue & Cell|August 29, 2022
LPS-mediated activation of TLR4 controls Toxoplasma gondii growth in human trophoblast cell (BeWo) and human villous explants in a dependent-manner of TRIF, MyD88, NF-κB and cytokinesAlessandra Monteiro Rosini, Samuel Cota Teixeira, Iliana Claudia Balga Milian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2017
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning RegimenAnna Dodero, Francesca Patriarca, Giuseppe Milone, et al.
Pageof 102

Showing results (781-790 of 1,012) with videos related to

Sort By:
Pageof 102
The Lancet. Haematology|July 5, 2024
Diagnosis and management of Evans syndrome in adults: first consensus recommendationsBruno Fattizzo, Monia Marchetti, Marc Michel, et al.
European Heart Journal|April 23, 2009
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stentsGiampaolo Niccoli, Domenico Schiavino, Flavia Belloni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2019
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective StudyFederica Sora, Carmen Di Grazia, Patrizia Chiusolo, et al.
Transplantation and Cellular Therapy|February 8, 2022
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance TreatmentMarta Reinoso-Segura, Teresa Caballero-Velázquez, Pilar Herrera, et al.
Obstetrics and Gynecology|February 20, 2010
Genetic analysis of the cause of endometrial osseous metaplasiaRaphael Câmara Medeiros Parente, Marisa Teresinha Patriarca, Rodrigo Soares de Moura Neto, et al.
The Oncologist|May 25, 2026
Add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: a randomized phase 3 studyJean-Jacques Kiladjian, Uma Borate, Elisabetta Abruzzese, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2017
Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple MyelomaLuisa Giaccone, Andrea Evangelista, Francesca Patriarca, et al.
Revista Brasileira De Parasitologia Veterinaria = Brazilian Journal of Veterinary Parasitology : Orgao Oficial Do Colegio Brasileiro De Parasitologia Veterinaria|July 27, 2012
Hematological alterations during experimental canine infection by Trypanosoma cruziPaulo Marcos Matta Guedes, Vanja Maria Veloso, Tiago Wilson Patriarca Mineo, et al.
Tissue & Cell|August 29, 2022
LPS-mediated activation of TLR4 controls Toxoplasma gondii growth in human trophoblast cell (BeWo) and human villous explants in a dependent-manner of TRIF, MyD88, NF-κB and cytokinesAlessandra Monteiro Rosini, Samuel Cota Teixeira, Iliana Claudia Balga Milian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2017
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning RegimenAnna Dodero, Francesca Patriarca, Giuseppe Milone, et al.
Pageof 102